My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 783

    1.

    Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

    Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA.

    Ann Intern Med. 2001 Jan 16;134(2):89-95.PMID: 11177311 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.

    Lindberg BU, Broomé U, Persson B.

    Dis Colon Rectum. 2001 Jan;44(1):77-85.PMID: 11805567 [PubMed - indexed for MEDLINE]Related articles

    3.

    The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.

    Wolf JM, Rybicki LA, Lashner BA.

    Aliment Pharmacol Ther. 2005 Nov 1;22(9):783-8.PMID: 16225486 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

    Gurbuz AK, Giardiello FM, Bayless TM.

    Dis Colon Rectum. 1995 Jan;38(1):37-41.PMID: 7813342 [PubMed - indexed for MEDLINE]Related articles

    5.

    Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.

    Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD.

    Gastroenterology. 2003 Apr;124(4):889-93.PMID: 12671884 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevention of colon cancer with ursodiol in ulcerative colitis.

    Kim HS.

    Inflamm Bowel Dis. 2001 Aug;7(3):279-80. No abstract available. PMID: 11515858 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research.

    Hawk ET, Viner JL.

    Ann Intern Med. 2001 Jan 16;134(2):158-60. No abstract available. PMID: 11177320 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Ursodiol for all?

    Lee SD, Surawicz CM.

    Am J Gastroenterol. 2001 Dec;96(12):3437-8. No abstract available. PMID: 11774966 [PubMed - indexed for MEDLINE]Related articles

    9.

    Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.

    Aitola P, Mattila J, Matikainen M.

    Int J Colorectal Dis. 2000 Jun;15(3):167-71.PMID: 10954188 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.

    Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO.

    Gastrointest Endosc. 2002 Jul;56(1):48-54.PMID: 12085034 [PubMed - indexed for MEDLINE]Related articles

    11.

    Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

    Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A.

    Gastroenterology. 2004 Feb;126(2):451-9.PMID: 14762782 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.

    Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin CE.

    Gastroenterology. 1996 Feb;110(2):331-8.PMID: 8566577 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.

    D'Haens GR, Lashner BA, Hanauer SB.

    Am J Gastroenterol. 1993 Aug;88(8):1174-8.PMID: 8338083 [PubMed - indexed for MEDLINE]Related articles

    14.

    Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study.

    Ståhlberg D, Veress B, Tribukait B, Broomé U.

    Dis Colon Rectum. 2003 Jun;46(6):770-8.PMID: 12794579 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital.

    Kottachchi D, Yung D, Marshall JK.

    Can J Gastroenterol. 2009 Sep;23(9):613-7.PMID: 19816624 [PubMed - indexed for MEDLINE]Related articles

    16.

    Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance.

    Holzmann K, Klump B, Borchard F, Gregor M, Porschen R.

    Dis Colon Rectum. 2001 Oct;44(10):1446-55.PMID: 11598473 [PubMed - indexed for MEDLINE]Related articles

    17.

    Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.

    Lindberg J, Stenling R, Palmqvist R, Rutegård J.

    J Pediatr Gastroenterol Nutr. 2008 May;46(5):534-8.PMID: 18493208 [PubMed - indexed for MEDLINE]Related articles

    18.

    Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.

    Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL.

    Inflamm Bowel Dis. 2006 Mar;12(3):205-11.PMID: 16534422 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.

    Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R.

    Anticancer Res. 2004 Sep-Oct;24(5B):3121-7.PMID: 15510599 [PubMed - indexed for MEDLINE]Related articles

    20.

    Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.

    Broomé U, Löfberg R, Veress B, Eriksson LS.

    Hepatology. 1995 Nov;22(5):1404-8.PMID: 7590655 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity